Clinical Report: Dry Eye: Addressing Diabetic Keratopathy

Overview

Diabetic keratopathy (DK) is a significant corneal disorder affecting 46% to 64% of diabetic patients, often misdiagnosed as dry eye disease (DED). Effective management requires understanding its unique pathophysiology and addressing systemic glucose control.

Background

Diabetic keratopathy is a critical condition that can severely impact vision in diabetic patients. It is characterized by corneal changes such as delayed wound healing and decreased corneal sensitivity, which are exacerbated by hyperglycemia. Recognizing and managing DK is essential to prevent complications and improve patient outcomes.

Data Highlights

No numerical data available in the source material.

Key Findings

• Approximately 46% to 64% of diabetic patients develop diabetic keratopathy.
• DK is caused by a hyperglycemic environment leading to oxidative stress and chronic inflammation.
• Common clinical manifestations include persistent epithelial defects, corneal ulcers, and reduced tear production.
• Management strategies include systemic glucose control, preservative-free artificial tears, and topical insulin drops.
• Patients often respond poorly to treatments while in a hyperglycemic state.

Clinical Implications

Clinicians should prioritize the identification of diabetic keratopathy in patients with diabetes to prevent misdiagnosis and ensure appropriate treatment. Collaborating with primary care providers to manage blood glucose levels is crucial for improving patient outcomes.

Conclusion

Diabetic keratopathy is a prevalent and serious condition that requires careful diagnosis and management. Understanding its distinct characteristics can enhance the visual health of diabetic patients.

References

1. Zhang X, Zhao L, Deng S, Sun X, Wang N, J Ophthalmol, 2016 -- Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics
2. Priyadarsini S, Whelchel A, Nicholas S, et al., Surv Ophthalmol, 2020 -- Diabetic keratopathy: insights and challenges
3. Buonfiglio F, Wasielica-Poslednik J, Pfeiffer N, Gericke A, Antioxidants, 2024 -- Diabetic keratopathy: redox signaling pathways and therapeutic prospects
4. Contact Lens Spectrum — Dry Eye Dx and Tx
5. Contact Lens Spectrum — DRY EYE DX AND TX
6. Optometric Management — CLINICAL: Dry Eye Recommendations
7. Contact Lens Spectrum — Dry Eye Dx and Tx
8. Knowledge, attitudes, and practices regarding keratopathy among diabetic patients
9. Dry Eye Syndrome Preferred Practice Pattern® - Icahn School of Medicine at Mount Sinai
10. Randomised controlled trial on effects of topical insulin compared to artificial tears and normal saline on tear inflammatory mediator levels and clinical parameters in diabetics with dry eye disease - PubMed